Investor Stock List
Ranked #1,485 of 8,699 institutional investors

Venrock Adviser, LLC

New York, NY

$2.07B
US stock portfolio at live prices · today +$37.3M (+1.83%)
Market closed. Prices as of Nov 20, 9:11 AM ET
Value at quarter end (Q3 2026)
$2.06B
Change from Q2 2026
−$1.24B (−37.59%)
Positions
27 · 3 new, 2 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$157M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
ORKA 19.5%ERAS 13.8%SYRE 11.7%KRSA 7.77%VRDN 4.94%
StockSharesValue, live% of portfoliovs Q2 2026
ORKA Oruka Therapeutics, Inc.4,148,428$405M19.5%Unchanged
ERAS Erasca, Inc.20,089,932$286M13.8%Added +12%
SYRE Spyre Therapeutics, Inc.2,485,448$243M11.7%Reduced −17%
KRSA Korsana Biosciences, Inc.4,549,585$161M7.77%New
VRDN Viridian Therapeutics, Inc.3,257,917$102M4.94%Unchanged
SVRA Savara Inc.19,568,534$102M4.91%Added +33%
DNTH Dianthus Therapeutics, Inc.822,020$69.7M3.36%Reduced −30%
OCUL Ocular Therapeutix, Inc.10,346,926$60.6M2.92%Unchanged
VOR Vor Biopharma Inc.3,041,719$56.3M2.72%Unchanged
MAZE Maze Therapeutics, Inc.1,545,616$50.1M2.42%Reduced −4%
JBIO Jade Biosciences, Inc.3,220,364$48.5M2.34%Unchanged
COGT Cogent Biosciences, Inc.1,642,166$45.6M2.20%Unchanged
DYN Dyne Therapeutics, Inc.2,173,913$34.8M1.68%Unchanged
QUIT Achieve Life Sciences, Inc.5,502,064$32.3M1.56%Added +100%
ANL Adlai Nortye Group Ltd.3,212,731$29.1M1.40%Unchanged
RLMD Relmada Therapeutics, Inc.7,445,050$23.2M1.12%Added +9%
ADRX ADARx Pharmaceuticals, Inc.1,625,793$23.0M1.11%New
ORIC ORIC Pharmaceuticals, Inc.2,944,056$22.7M1.09%Reduced −32%
XFOR X4 Pharmaceuticals, Inc.7,644,072$22.6M1.09%Added +295%
SRZN Surrozen, Inc.632,931$19.4M0.94%Unchanged
PBLS Parabilis Medicines, Inc.625,000$17.3M0.83%Unchanged
ANRO Alto Neuroscience Inc500,000$13.3M0.64%Unchanged
ARVN Arvinas, Inc.1,952,533$13.2M0.63%New
CGEM Cullinan Therapeutics, Inc.1,379,965$12.5M0.60%Unchanged
IPSC Century Therapeutics, Inc.8,695,652$11.5M0.55%Unchanged
ARTV Artiva Biotherapeutics, Inc.2,043,596$7.8M0.38%Unchanged
KRRO Korro Bio, Inc.443,431$5.4M0.26%Reduced −56%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ELVN Enliven Therapeutics, Inc.526,331$24.4M
CTMX CytomX Therapeutics, Inc.4,982,124$10.2M